Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist.

Sciberras, D G

Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist. [electronic resource] - British journal of clinical pharmacology Jan 1997 - 49-54 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0306-5251

10.1111/j.1365-2125.1997.tb00032.x doi


Administration, Oral
Adult
Analysis of Variance
Blood Pressure--drug effects
Double-Blind Method
Heart Rate--drug effects
Humans
Male
Migraine Disorders--metabolism
Serotonin Receptor Agonists--adverse effects
Sumatriptan--pharmacokinetics
Triazoles--adverse effects
Tryptamines